Back to search

Article

Real-World Data of Off-Label Drug Use in Patients with Actionable Genomic Alterations on Next-Generation Sequencing

2021-12-30

Abstract excerpt

<title>Abstract</title> <p>We analyzed the outcomes of patients in our institution treated with off-label drugs targeting actionable genomic alteration based on next-generation sequencing when clinical trials were not available. Our study endpoint was objective tumor response or stable disease at 16 weeks or later after treatment initiation. Sixteen patients were included in this study, 8 were treated with immune...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
de664150-abc3-544b-8d5c-0190f5606419
DOI
10.21203/rs.3.rs-1138772/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-World Data of Off-Label Drug Use in Patients with Actionable Genomic Alterations on Next-Generation SequencingDOI 10.21203/rs.3.rs-1138772/v1
Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing.Semantic proximity
Quantitation of Targetable Somatic Mutations Among Patients Evaluated by a Personalized Medicine Clinical Service: Considerations for Off-Label Drug Use.Semantic proximity
Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II Study Protocol KCSG AL-22-09Semantic proximity
Comprehensive tumor molecular profile analysis in clinical practice.Semantic proximity
A Comprehensive Tumor Molecular Profile Analysis in Clinical Practice: A Single Center’s ExperienceSemantic proximity
On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients.Semantic proximity
The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular ProfileSemantic proximity
Clinical Benefit and Agenda for Clinical Sequencing Using Cancer Panel Testing: A Retrospective Clinical StudySemantic proximity
Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.Semantic proximity
Impact of next-generation sequencing on routine clinical practice and patient inclusion in molecularly targeted clinical trials: a retrospective cohort analysis.Semantic proximity
Impact of tumor sequencing on the use of anticancer drugsSemantic proximity
Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.Semantic proximity
Select a neighboring publication to make it the new centre.